{"text": "Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma : clinical relevance and effects of cytokine therapy .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Studies have demonstrated abnormalities of the CD3 / T-cell antigen receptor ( TCR ) and pathways of signal transduction in T lymphocytes from animals and patients with advanced malignancy .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Diminished expression of <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> and <extra_id_0> p56(lck) <extra_id_2> Protein <extra_id_1> that are associated with the TCR and reduced nuclear localization of <extra_id_0> RelA <extra_id_2> Protein <extra_id_1> containing nuclear factor kappaB ( NFkappaB ) complexes have been noted .", "event": "<extra_id_0> <extra_id_0> Negative_regulation Diminished <extra_id_0> Theme expression <extra_id_1> <extra_id_1> <extra_id_0> Negative_regulation Diminished <extra_id_0> Theme expression <extra_id_1> <extra_id_1> <extra_id_0> Gene_expression expression <extra_id_0> Theme TCRzeta <extra_id_1> <extra_id_1> <extra_id_0> Gene_expression expression <extra_id_0> Theme p56(lck) <extra_id_1> <extra_id_1> <extra_id_0> Binding associated <extra_id_0> Theme TCRzeta <extra_id_1> <extra_id_1> <extra_id_0> Binding associated <extra_id_0> Theme p56(lck) <extra_id_1> <extra_id_1> <extra_id_0> Negative_regulation reduced <extra_id_0> Theme localization <extra_id_1> <extra_id_1> <extra_id_0> Localization localization <extra_id_0> Theme RelA <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "These defects have been described in T cells from patients with malignant melanoma , renal cell carcinoma ( RCC ) , ovarian cancer , and colorectal cancer .", "event": "<extra_id_0> <extra_id_0> Negative_regulation defects <extra_id_1> <extra_id_1>"}
{"text": "Preliminary observations also indicate possible correlation with clinical variables such as stage in selected instances .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "To further characterize altered expression of <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> , <extra_id_0> p56(lck) <extra_id_2> Protein <extra_id_1> , and impaired activation of NFkappaB , T lymphocytes were obtained from 65 patients with RCC , the majority of whom were receiving combination cytokine therapy [ <extra_id_0> interleukin (IL)-2 <extra_id_2> Protein <extra_id_1> , <extra_id_0> IFN alpha <extra_id_2> Protein <extra_id_1> - containing regimens ] and 37 control individuals .", "event": "<extra_id_0> <extra_id_0> Negative_regulation altered <extra_id_0> Theme expression <extra_id_1> <extra_id_1> <extra_id_0> Negative_regulation altered <extra_id_0> Theme expression <extra_id_1> <extra_id_1> <extra_id_0> Gene_expression expression <extra_id_0> Theme TCRzeta <extra_id_1> <extra_id_1> <extra_id_0> Gene_expression expression <extra_id_0> Theme p56(lck) <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "In 29 of these patients , levels of <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> and <extra_id_0> p56(lck) <extra_id_2> Protein <extra_id_1> were determined by Western blots of T-cell lysates and semiquantitated using densitometry .", "event": "<extra_id_0> <extra_id_0> Gene_expression levels <extra_id_0> Theme TCRzeta <extra_id_1> <extra_id_1> <extra_id_0> Gene_expression levels <extra_id_0> Theme p56(lck) <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "Relative levels were then correlated with a series of clinical variables including response to therapy , performance status , survival , disease sites , age , and others .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "In another group of 28 patients ( three individuals from the first group ) , the frequency of abnormal NFkappaB activation was studied using electrophoretic mobility shift assays after activation of T cells with phorbol myristate acetate / ionomycin or anti-CD3 monoclonal antibody .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Changes in these signaling molecules during cytokine treatment were also investigated .", "event": "<extra_id_0> <extra_id_0> Positive_regulation Changes <extra_id_1> <extra_id_1>"}
{"text": "<extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> and <extra_id_0> p56(lck) <extra_id_2> Protein <extra_id_1> were detected in the peripheral blood T cells in 27 of 29 patients , and overall , reduced levels were noted visually in 12 of 29 ( 41 % ) and 13 of 29 ( 45 % ) individuals , respectively .", "event": "<extra_id_0> <extra_id_0> Gene_expression detected <extra_id_0> Theme TCRzeta <extra_id_1> <extra_id_1> <extra_id_0> Gene_expression detected <extra_id_0> Theme p56(lck) <extra_id_1> <extra_id_1> <extra_id_0> Negative_regulation reduced <extra_id_0> Theme detected <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "When levels were semiquantitated using densitometry , significant decreases of <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> ( P = 0.029 ) and <extra_id_0> p56(lck) <extra_id_2> Protein <extra_id_1> ( P = 0.029 ) but not <extra_id_0> CD3epsilon <extra_id_2> Protein <extra_id_1> ( P = 0.131 ) , compared with control levels , were found .", "event": "<extra_id_0> <extra_id_0> Negative_regulation decreases <extra_id_0> Theme CD3epsilon <extra_id_1> <extra_id_1> <extra_id_0> Negative_regulation decreases <extra_id_0> Theme TCRzeta <extra_id_1> <extra_id_1> <extra_id_0> Negative_regulation decreases <extra_id_0> Theme p56(lck) <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "In patients treated with <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> / <extra_id_0> IFN alpha <extra_id_2> Protein <extra_id_1> - based therapy , relative levels of <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> increased significantly ( P = 0.002 ) on day 15 of cycle one compared with the baseline .", "event": "<extra_id_0> <extra_id_0> Positive_regulation increased <extra_id_0> Theme TCRzeta <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "Correlations of <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> or <extra_id_0> p56(lck) <extra_id_2> Protein <extra_id_1> levels with response or disease variables , except for lower <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> levels ( P < 0.001 ) in the presence of bone metastases , were not found .", "event": "<extra_id_0> <extra_id_0> Negative_regulation lower <extra_id_0> Theme TCRzeta <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "Abnormal NFkappaB activation after stimulation with phorbol myristate acetate / ionomycin and / or anti-CD3 monoclonal antibody was found in 59 % of patients ( 17 of 28 ) and was not accounted for by the advanced age of the study cohort .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Activation of NFkappaB in peripheral blood T cells was inducible during cytokine therapy in four of six individuals who displayed impaired NFkappaB activity prior to therapy .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Moreover , impaired activation of NFkappaB does not appear linked to a reduction of <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> expression , because in five patients , normal <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> levels were present although kappaB binding was not inducible .", "event": "<extra_id_0> <extra_id_0> Negative_regulation reduction <extra_id_0> Theme expression <extra_id_1> <extra_id_1> <extra_id_0> Gene_expression expression <extra_id_0> Theme TCRzeta <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "In the majority of patients with advanced RCC , peripheral blood T cells express <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> and <extra_id_0> p56(lck) <extra_id_2> Protein <extra_id_1> , and in a subset , reduced levels of these <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> associated molecules are seen that may increase during cytokine-based therapy .", "event": "<extra_id_0> <extra_id_0> Gene_expression express <extra_id_0> Theme TCRzeta <extra_id_1> <extra_id_1> <extra_id_0> Gene_expression express <extra_id_0> Theme p56(lck) <extra_id_1> <extra_id_1> <extra_id_0> Negative_regulation reduced levels <extra_id_0> Theme TCRzeta <extra_id_1> <extra_id_1> <extra_id_0> Negative_regulation reduced levels <extra_id_0> Theme p56(lck) <extra_id_1> <extra_id_1> <extra_id_0> Positive_regulation increase <extra_id_0> Theme reduced levels <extra_id_1> <extra_id_1> <extra_id_0> Positive_regulation increase <extra_id_0> Theme reduced levels <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "Abnormal activation of NFkappaB is also present in > 50 % of patients and may also revert to normal during <extra_id_0> IL-2 <extra_id_2> Protein <extra_id_1> / I <extra_id_0> FN alpha <extra_id_2> Protein <extra_id_1> - based treatment .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "This alteration in NFkappaB activation occurred in the presence of normal expression of <extra_id_0> TCRzeta <extra_id_2> Protein <extra_id_1> - associated signaling elements .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The clinical significance of these findings remains unclear .", "event": "<extra_id_0> <extra_id_1>"}
